C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu
Ernst Lengyel(University of Illinois Chicago), Nadia Harbeck(Breast Center), Beatrice S. Knudsen(University of Utah), Kristina Lindemann(Norwegian Cancer Society), James H. Resau(Cancer Research Center), Anita Welk(Technical University of Munich), Georgia Salanti(University of Bern), George F. Vande Woude(Van Andel Institute), Dieter Prechtel(Technical University of Munich), Thomas Richter(Technical University of Munich), K. Gauger(Technical University of Munich)
Cited by 268
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
|Journal of Clinical Epidemiology|2010|3.8k
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.5k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k